misetionamide
Phase 2- Indications
- Pancreatic Cancer
Company intelligence / Profile preview
Geistlich Pharma AG
Wolhusen, Central Switzerland, Switzerlandgeistlich-na.com ↗
- Ownership
- Private
- Employees
- ~800
- Development stage
- Commercial
01
Overview
Geistlich is a global market leader in regenerative dentistry with products used every 14 seconds worldwide. Their portfolio includes bone replacement material Geistlich Bio-Oss® and collagen membrane Geistlich Bio-Gide®, both developed in the 1980s[1][2].
- Therapeutic areas
- OtherNeurologyRheumatology
- Modalities
- BiomaterialsRegenerative medical devices
- Industry
- Implantable Medical Devices
02
Drug pipeline
1 asset03
Partnerships
Meta Technologies S.r.l.Lynch Biologics LLCBionnovation Biomedical
Beyond the preview
Go deeper on Geistlich Pharma AG.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Geistlich Pharma AG.